Selected article for: "ii expression and MHC expression"

Author: Marriott, Andrew S.; Vasieva, Olga; Fang, Yongxiang; Copeland, Nikki A.; McLennan, Alexander G.; Jones, Nigel J.
Title: NUDT2 Disruption Elevates Diadenosine Tetraphosphate (Ap(4)A) and Down-Regulates Immune Response and Cancer Promotion Genes
  • Document date: 2016_5_4
  • ID: 0ozzbp85_53
    Snippet: MYOC and NEUROG1 was detected so their significance is hard to determine. In the case of MHC-II genes, SMC3, a subunit of the cohesin protein complex, was identified as a possible regulator. Cohesin co-operates with MHC-II specific transcription factors RFX5 and CIITA (up 1.3-fold) to activate MHC-II expression [136] . SMC3 has an ATP-binding domain but whether cohesin binding to MHC-II transcriptional insulators could be promoted by Ap 4 A is un.....
    Document: MYOC and NEUROG1 was detected so their significance is hard to determine. In the case of MHC-II genes, SMC3, a subunit of the cohesin protein complex, was identified as a possible regulator. Cohesin co-operates with MHC-II specific transcription factors RFX5 and CIITA (up 1.3-fold) to activate MHC-II expression [136] . SMC3 has an ATP-binding domain but whether cohesin binding to MHC-II transcriptional insulators could be promoted by Ap 4 A is unknown. The ubiquitin E3 ligase PDLIM2 (SLIM) is predicted by IPA 1 to both up-regulate and down-regulate different sets of genes (S8 Table) . This prediction appears to be based largely on the results of one previous investigation into PDLIM2-modulated gene expression in DU145 prostate carcinoma cells [137] and the direction of expression change of about half the genes in that study is different from that in ours. Given that the z-scores for the predictions are both below the significance threshold of 2
    Search related documents:
    Co phrase search for related documents
    • ATP bind domain and protein kinase: 1
    • carcinoma cell and expression change: 1, 2
    • carcinoma cell and gene expression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46
    • carcinoma cell and NuKO cell: 1
    • carcinoma cell and prostate carcinoma cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • carcinoma cell and protein complex: 1
    • carcinoma cell and protein kinase: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • carcinoma cell and regulate gene: 1
    • carcinoma cell and secondary effect: 1
    • carcinoma cell and significantly affect: 1
    • carcinoma cell and study gene: 1, 2, 3, 4, 5, 6, 7
    • carcinoma cell and transcription factor: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • change secondary effect and secondary effect: 1